Recommended Dose for Post-Infectious Cough
For adults with severe paroxysms of post-infectious cough, prescribe 30 to 40 mg of oral prednisone daily for a short, finite period of time (typically 2-3 weeks with a taper), but only after ruling out other common causes of cough such as upper airway cough syndrome, asthma, or gastroesophageal reflux disease. 1
Clinical Context and Timing
Post-infectious cough is defined as cough lasting 3 to 8 weeks following an acute respiratory infection. The ACCP guidelines emphasize that oral corticosteroids should be reserved for severe paroxysms that significantly impact quality of life, not for routine post-infectious cough 1.
Important Caveats:
- First-line therapy should be inhaled ipratropium (fair evidence, grade B recommendation) 1
- Inhaled corticosteroids should be tried before oral steroids if cough persists despite ipratropium and adversely affects quality of life 1
- Oral corticosteroids are only considered when these measures fail
Dosing Algorithm
For Adults:
- Dose: 30-40 mg prednisone (or prednisolone equivalent) daily
- Duration: Short, finite period (typically starting dose for 2-3 weeks, then taper to zero over 2-3 weeks based on uncontrolled studies) 1
- Timing: Morning administration preferred (per standard corticosteroid dosing principles) 2
For Children:
No specific recommendation exists for oral corticosteroids in post-infectious cough in children. The guidelines explicitly state that corticosteroids should not be offered to patients with whooping cough (pertussis), as there is no evidence of benefit 1.
For viral respiratory infections in children aged 6-35 months, one study used 2 mg/kg/day of prednisolone for 3 days and showed benefit 3, but this was for acute viral lower respiratory tract infection, not post-infectious cough specifically.
Critical Exclusions Before Prescribing
You must rule out these conditions first, as they require different management:
- Upper airway cough syndrome (UACS) due to rhinosinus diseases
- Asthma or bronchial hyperresponsiveness
- Gastroesophageal reflux disease
- Bacterial sinusitis
- Bordetella pertussis infection (especially if early in course)
If cough persists beyond 8 weeks, reconsider the diagnosis entirely—it's likely not post-infectious cough 1.
Evidence Quality and Nuances
The recommendation for oral corticosteroids carries low-quality evidence with intermediate benefit (Grade C) 1. This is based on uncontrolled studies showing benefit with 30-40 mg prednisone tapered over 2-3 weeks 1.
Importantly, a high-quality 2017 RCT in adults with acute lower respiratory tract infection found that 40 mg prednisolone daily for 5 days did NOT reduce cough duration or severity 4. However, this studied acute infection, not the post-infectious phase (3-8 weeks after infection), which is thought to have different inflammatory mechanisms.
The pathophysiology involves postviral airway inflammation with bronchial hyperresponsiveness, mucus hypersecretion, and impaired mucociliary clearance 1. The rationale for corticosteroids is to suppress this inflammatory cascade, similar to asthma exacerbations.
Common Pitfalls to Avoid
- Don't prescribe oral steroids as first-line therapy—this skips safer, evidence-based options (ipratropium, inhaled corticosteroids)
- Don't use antibiotics—they have no role unless bacterial sinusitis or early pertussis is confirmed 1
- Don't continue steroids indefinitely—use a finite course with taper
- Don't assume all persistent cough is post-infectious—if duration exceeds 8 weeks, investigate other etiologies 1
- Don't use oral steroids in children with post-infectious cough—evidence is lacking and guidelines recommend against corticosteroids for pertussis 1
Practical Implementation
When prescribing the 30-40 mg daily dose:
- Start with 30-40 mg once daily in the morning
- Continue for approximately 1 week at full dose
- Taper gradually over 1-2 weeks (e.g., reduce by 5-10 mg every few days)
- Total treatment duration typically 2-3 weeks 1
- Monitor for steroid side effects (hyperglycemia, mood changes, insomnia, gastric irritation)
- Re-evaluate if no improvement within 1 week—consider alternative diagnoses
The FDA labeling confirms that prednisolone dosing is highly individualized (ranging from 5-60 mg/day depending on condition severity), supporting the 30-40 mg range for inflammatory respiratory conditions 2.